RFA for Development of Point-Of-Care Testing for HIV and Co-Morbidities for Use in Low and Middle Income Countries
The Center for Innovation in Point-of-Care Technologies for HIV/AIDS at Northwestern University (C-THAN) seeks collaborative research projects to develop novel point-of-care technologies (POCT) aimed at improving diagnosis and treatment monitoring of HIV/AIDS in low- and middle-income countries (LMIC). If successful, projects should be viable candidates for commercial development. Domestic and foreign institutions are eligible for awards up to $100,000 (total costs).
View the full RFA>>
|
|
ISGMH Names Jagadīśa-devaśrī Dācus, PhD as New Associate Director
The Institute for Sexual and Gender Minority Health and Wellbeing (ISGMH) at Northwestern University has named Jagadīśa-devaśrī Dācus, PhD, LMSW, as its new Associate Director. Dācus comes to ISGMH from the HIV Center for Clinical and Behavioral Studies at Columbia University and the New York State Psychiatric Institute, where he studied HIV-negative Black men who have sex with men (MSM) and the resiliencies that contribute to this population’s ability to stay HIV-negative. The Third Coast CFAR welcomes Dr. Dācus to Chicago and looks forward to future HIV research collaborations.
View the announcement on the ISGMH website>>
|
|
NIH Office of AIDS Research Releases Stakeholder Outreach and Engagement Report
The NIH Office of AIDS Research (OAR) recently released a report on its stakeholder outreach and engagement activities that helped inform and harmonize the NIH Strategic Plan for HIV and HIV-Related Research and overarching NIH HIV/AIDS research priorities for 2021–2025. This report includes feedback from the listening session the Third Coast CFAR hosted on September 24, 2019, with OAR Deputy Director, Captain Timothy Sholtz, and OAR Scientist and Senior Advisor, Captain Mary Glenshaw. Sixty Chicago-area HIV scientists, advocates, providers, public health professionals, and community representatives gave feedback on OAR’s draft plan for strategic priorities and identified opportunities for NIH to support new research initiatives. Following the listening session, Howard Brown Health invited the OAR leaders to meet with patients and providers at the 63rd Street site.
View the report>>
|
|
|
|
|
Impact of the gut microbiota on stem cell and solid organ transplantation
Monday, March 15, 2021
12–1 p.m. CT
Livestream Only
RSVP Required
Dr. Pamer is the Director of the Duchossois Family Institute and the Donald F. Steiner Professor in the Departments of Medicine, Microbiology, and Pathology at the University of Chicago. His research focuses on the impact of the intestinal microbiota on resistance to Vancomycin-resistant Enterococcus faecium, Clostridium difficile and Klebsiella pneumoniae infections in patients receiving cancer treatment, with a specific focus on highly immunocompromised patients undergoing allogeneic hematopoietic stem cell transplantation. The Pamer laboratory also investigates the role of inflammatory monocytes in defense against infection and the interaction between intestinal microbes and the mammalian immune system. Discussion will include opportunities for HIV research collaborations with the Pamer lab.
|
Eric G. Pamer, MD
Director, Duchossois Family Institute
Donald F. Steiner Professor
Departments of Medicine, Microbiology, and Pathology
Biological Sciences Division
The University of Chicago
|
|
Data-Driven, Care Delivered: Howard Brown Health’s Community-Focused Pandemic Response
Monday, March 22, 2021
12–1 p.m. CT
Livestream Only
RSVP Required
Dr. Catherine Creticos is the Medical Director of Clinical Research at Howard Brown Health, a Clinical Assistant Professor of Medicine at the University of Illinois at Chicago, the Chief of the Section of Infectious Diseases at Advocate Illinois Masonic Medical Center, and the Illinois Medical Director of the Midwest AIDS Training and Education Center. Creticos is also the principal investigator on a number of clinical research studies and has been active in the treatment of patients with COVID-19 infection and research projects addressing the treatment and prevention of COVID-19 infection.
|
Cathy Creticos, MD
Medical Director of Clinical Research
Director of Infectious Diseases
Howard Brown Health
|
|
|
NIH Notices pertaining to HIV/AIDS
Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders
NOT-DA-21-018
NIDA
Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19
NOT-DA-21-017
NIDA
Funding Opportunities Pertaining to HIV/AIDS
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed)
RFA-DA-22-004
NIDA
Application Receipt Date(s): July 14, 2021
Human Immunology Project Consortium
RFA-AI-20-07 (U19 Clinical Trial Optional)
NIAID
Application Receipt Date(s): June 4, 2021
|
|
|
|
